S&P Global Ratings believes that UnitedHealth’s overall strategy, focusing on diversified insurance and health care services growth, remains sound. However, the company underestimated the negative ...

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper published a salacious investigative report alleging the company intentionally ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based ...

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group shares appear undervalued after 50% decline, and concerns about a potential DOJ investigation seem ...

UnitedHealth Group's new CEO Steve Hemsley on Monday told shareholders he was determined to earn back their trust after its ...

Witty, who largely led the U.S. healthcare giant from the U.K., made big bets on Medicare enrollees that backfired.

Despite rumblings of dissatisfaction, UnitedHealth shareholders voted to support a $60 million stock package for CEO Stephen Hemsley.

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...